Author:
Uzba Khanam ,Mohd Omar ,R. Rajareddy
Abstract
Objective of the research work is Design of experiment of Albendazole Chewable Tablets 400 mg without overages of API and preservatives with Quality by Design (QbD) Approach. Development trials of Albendazole Chewable Tablets 400 mg have been carried out with the remove of overages of API and preservatives (Parabens) from the established formula of Albendazole Chewable Tablets 400 mg to finalize the manufacturing process and specifications. Trial batch was evaluated for feasibility of manufacturing process and designed target product profile.
Reference8 articles.
1. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Sachs SE, J.D. SachsIncorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria A comprehensive pro-poor health policy and strategy for the developing world.
2. P.J. Hotez Neglected diseases and poverty in ”The Other America”: the greatest health disparity in the United States? PLOS Negl Trop Dis Public Libr Sci. 2007 Dec 26;1(3):e149.
3. Crompton DW, Nesheim MC. Nutritional impact of intestinal helminthiasis during the human life cycle. Annu Rev Nutr. 2002;22:35-59. doi: 10.1146/annurev.nutr.22.120501.134539, PMID 12055337.
4. Miguel E, Kremer M. Worms: identifying impacts on education and health in the presence of treatment externalities. Econometrica. 2004;72(1):159-217. doi: 10.1111/j.1468-0262.2004.00481.x.
5. WHO/OIE manual on echinococcosis in humans and animals: a public health problem of global concern; 2001.